Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
about
The bright side of being blue: depression as an adaptation for analyzing complex problemsThe role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.Monoamine depletion in psychiatric and healthy populations: review.Neural response to eye contact and paroxetine treatment in generalized social anxiety disorderPrimum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan.Psychoactive medication use and neurocognitive function in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor study.A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression.Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosisThe effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review.PTSD, Psychotropic Medication Use, and the Risk of Dementia Among US Veterans: A Retrospective Cohort Study.Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls.Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory.Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment.Gender differences in the association between antidepressant use and restless legs syndrome.Cognitive performance of juvenile monkeys after chronic fluoxetine treatment.Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes.Opposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex.Modulation of attention network activation under antidepressant agents in healthy subjects.Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjects.Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children.Hypothyroidism and major depression: a common executive dysfunction?Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.
P2860
Q24645463-1089ACBC-3FDC-46B0-AA12-A183D8CA7A55Q34335586-9AA1FCC0-4FE1-48DD-BF6C-60C8B4C5EC24Q34543573-78C59BE4-BC17-464D-804D-89CBD9EDBB0FQ35591557-1DC217B3-2424-497F-A288-92DD194EBA07Q35907475-C20C3547-8C4C-47A8-B95C-2A4EB5568834Q36338197-0B3F95B4-FE9E-4F88-994E-4371725AFE4BQ36389088-46F39642-27C7-4A30-B55D-738D6C152C40Q37078954-3CACD65D-2297-4042-876E-81A271138E26Q37119780-7B740B39-C2E5-47F8-B015-D8EA2A709AC2Q37678438-5B06DD38-44B5-4331-B275-26B48195B72BQ40345304-4912D5EE-775F-49A9-89BE-0B4EB341F146Q43262225-D4CBA157-1185-4836-BCA2-CFB9DD058A5AQ43842107-EF406B5A-66CF-4A62-90DD-4250DDCCA068Q44374783-596DD29E-522D-4CC9-8D5D-80E3F10E40F7Q44858847-DC459EAF-BCF4-4626-A6EF-EBD6558FDF52Q45238690-93977EB0-46C2-4F14-AD70-BC85397E52A2Q46057248-922F0DE4-7CF6-4227-A1D6-DE1DD67A0653Q46639074-074A0F84-8643-4F27-89F0-6412F9D3F8E7Q47642074-4E7FE39B-7627-4225-B4EE-2F9292FB050BQ47849364-A0C703A1-599C-4240-8D82-EE35E735FE78Q47937723-5A64B4A3-5EA5-408B-B70D-2948D02AF567Q48131764-EFC03A8B-CE66-49FC-9477-68A22B3127B3Q50535136-74261E29-BB58-4A22-9E09-1521D29BD704Q50936776-4C606A9E-5BA5-46E9-A320-7091CFA0FC5AQ51481116-33F89D16-3CCB-4EE5-9680-D2641EEE3C25
P2860
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@ast
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@en
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@nl
type
label
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@ast
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@en
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@nl
prefLabel
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@ast
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@en
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@nl
P2093
P2860
P1476
Additional dopamine reuptake i ...... in reuptake inhibition in man.
@en
P2093
Eric F P M Vuurman
Jeroen A J Schmitt
Johannes G Ramaekers
Martin P J van Boxtel
Monique J Kruizinga
P2860
P304
P356
10.1177/026988110201600303
P407
P50
P577
2002-09-01T00:00:00Z